Hedgehog pathway overexpression in pancreatic cancer is abrogated by new-generation taxoid SB-T-1216. (Q38749227)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

title

Hedgehog pathway overexpression in pancreatic cancer is abrogated by new-generation taxoid SB-T-1216 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Iwao Ojima

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Pavel Souček

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author name string

B Mohelnikova-Duchonova

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

M Kocik

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

B Duchonova

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

V Brynychova

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

J Hlavsa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

E Honsova

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

J Mazanec

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Z Kala

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

D J Hughes

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

J E Doherty

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

H A Murray

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

M A Crockard

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

R Lemstrova

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

publication date

30 August 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

22 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

page(s)

452-460

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573236%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/tpj.2016.55

22 March 2020

exact match

0 references

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Design, synthesis, and biological evaluation of new-generation taxoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

A paracrine requirement for hedgehog signalling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Hedgehog pathway maintains cell survival under stress conditions, and drives drug resistance in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Sonic Hedgehog Pathway Activation Is Associated With Resistance to Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Differences in transcript levels of ABC transporters between pancreatic adenocarcinoma and nonneoplastic tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Expression of cytochrome P450 genes in CD34+ hematopoietic stem and progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Evaluation of reference genes and normalization strategy for quantitative real-time PCR in human pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Hedgehog/Ras interactions regulate early stages of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Loss of the transcription factor GLI1 identifies a signaling network in the tumor microenvironment mediating KRAS oncogene-induced transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

The dawn of hedgehog inhibitors: Vismodegib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Stromal response to Hedgehog signaling restrains pancreatic cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Second-generation taxanes effectively suppress subcutaneous rat lymphoma: role of disposition, transport, metabolism, in vitro potency and expression of angiogenesis genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Hedgehog Signaling in the Maintenance of Cancer Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2016.55

Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27573236

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27573236

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27573236